Shenzhen Hepalink Pharmaceutical Group Co., Ltd. announced the board has resolved not to declare a final dividend for the year ended 31 December 2023 (2022: RMB 1.0 per ten ordinary shares).
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.18 CNY | -0.29% | -2.21% | -13.21% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.21% | 1.86B | |
+21.28% | 44.4B | |
+24.60% | 23.03B | |
+18.18% | 15.14B | |
+12.87% | 13.12B | |
+44.67% | 11.85B | |
-8.33% | 6.99B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.22% | 5.52B |
- Stock Market
- Equities
- 002399 Stock
- News Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
- Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Announces No Final Dividend for the Year Ended 31 December 2023